These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7126345)

  • 1. [Evaluation of the efficacy of low-dose heparin prophylaxis in preventing thromboembolic complications in total hip prosthesis interventions].
    Gnudi S; Cagnano R; Figus F
    Boll Chim Farm; 1982 Feb; 121(2):29S-32S. PubMed ID: 7126345
    [No Abstract]   [Full Text] [Related]  

  • 2. Intraoperative adjusted-dose heparin thromboembolic prophylaxis in primary total hip arthroplasty.
    Huo MH; Salvati EA; Sharrock NE; Pellicci PM; Sculco TP; Go G; Mineo R; Brien WW
    Clin Orthop Relat Res; 1992 Apr; (277):188-96. PubMed ID: 1555341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombo-embolism as a complication of prosthetic replacement operations of the hip: prophylaxis with heparin at low doses.
    Gnudi S; Picci P; Figus E
    Ital J Orthop Traumatol; 1980 Apr; 6(1):147-51. PubMed ID: 7203996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hip arthroplasty and thromboembolic complications].
    Le Guyader HM; Perramant Y; Tepaut D; De Tinteniac A; Egreteau JP
    Agressologie; 1990 Mar; 31(3):155-7. PubMed ID: 2240407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thromboembolic disease in patients after total endoprosthesis hip joint surgery using small doses of heparin].
    Stĕdrý V; Slavík M; Ort J; Janotová H; Kapounek B
    Acta Chir Orthop Traumatol Cech; 1982 Oct; 49(5):406-12. PubMed ID: 7158196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic advances in thromboembolic disease. I. Dihydroergotamine + heparin].
    de Diego I; Jané F; Félez J
    Sangre (Barc); 1981; 26(4):471-83. PubMed ID: 7027494
    [No Abstract]   [Full Text] [Related]  

  • 7. [The risk of thromboembolism in prosthetic surgery of the hip, and its prevention by administration of individualized heparin dosages].
    Hernandez-Vaquero D
    Acta Orthop Belg; 1990; 56(2):445-50. PubMed ID: 2239191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of postoperative thromboembolic complications with low heparin doses (a review of the literature)].
    Nodel'son SE
    Khirurgiia (Mosk); 1983 May; (5):109-12. PubMed ID: 6348385
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of subcutaneous heparin used according to 2 protocols in the prevention of postoperative venous thrombosis after total hip prothesis].
    de Mourgues G; Pagnier F; Clermont N; Ville D; Moyen B
    Rev Chir Orthop Reparatrice Appar Mot; 1979; 65 Suppl 2():74-6. PubMed ID: 158800
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug prevention of thromboembolism in elective hip surgery with reference to thrombophilic conditions].
    Liedloff H; Brauckhoff KF
    Z Gesamte Inn Med; 1989 Jun; 44(11):320-3. PubMed ID: 2669388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of thromboembolic complications in the postoperative period by the subcutaneous administration of low heparin doses].
    Revskoĭ AK; Zhuraev TZh; Savitskiĭ GG; Suntsov VN; Taranov SV
    Khirurgiia (Mosk); 1980 Oct; (10):84-7. PubMed ID: 7431790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of the necessary time for prevention of thromboembolism using heparin/dihydroergotamine during implantation of partial hip joint endoprostheses].
    Maldini B; Matijasević B
    Acta Chir Iugosl; 1989; 36(1):169-78. PubMed ID: 2711804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombotic and thromboembolic complications and their prevention with heparin].
    Kucherskiĭ VM
    Urol Nefrol (Mosk); 1983; (2):69-74. PubMed ID: 6190288
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postoperative prevention of thromboembolism with low-dose heparin and micristine in total alloplastic hip joint replacement].
    Buchmann J; Bülow B; Jaster D; Popihn H
    Beitr Orthop Traumatol; 1982 May; 29(5):246-51. PubMed ID: 7126128
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations with subcutaneous heparin calcium used for the prevention of postoperative thromboembolism in orthopaedic surgery cases.
    Cser I
    Ther Hung; 1988; 36(1):16-9. PubMed ID: 3388286
    [No Abstract]   [Full Text] [Related]  

  • 18. [The optimization of the heparin prophylaxis of postoperative thromboembolic complications].
    Nozdrachev IuI
    Vestn Khir Im I I Grek; 1995; 154(2):61-5. PubMed ID: 8540191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboembolic complications after endoprosthesis of the hip joint].
    Tuszyński W; Rybicki Z
    Chir Narzadow Ruchu Ortop Pol; 1986; 51(4):275-8. PubMed ID: 3816380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thromboembolic complications following hip arthroplasty. Role of systematic heparin therapy (130 cases)].
    Raimbeau G; Galland F; Pidhorz L
    Ann Chir; 1983 May; 37(4):291-5. PubMed ID: 6625504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.